CSL889

· CSL Behring

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CSL889, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis [Phase 2]

See pricing